drugset / Trial / NCT00206414

Arimidex/Faslodex/Iressa Study: A Trial Using Arimidex, Faslodex and Iressa in Women With Breast Cancer

NCT00206414

Phase 2 Terminated 15 enrolled Baylor Breast Care Center
RandomizedParallel-groupOpen-labelTreatment

Summary

The investigators want to know if combining Arimidex and Faslodex with Iressa will be an effective treatment for breast cancer. They also want to know, using special tests on the tumor, the changes that occur with the treatment so they can try to improve their treatment for breast cancer in the future.

Timeline

Start
2003-01
Primary completion
2006-09
Completion
2006-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Gefitinib Small molecule
Background Anastrozole Other / unclassified
Background Fulvestrant Small molecule

Indications